abstract |
New 6-phenyldihydro-3 (2H) -pyridazinones of the general formula are described which, with good oral availability, are characterized by a high positive inotropic effectiveness and only slightly influence blood pressure and heart rate. Furthermore, a manufacturing process and pharmaceutical compositions containing these compounds are described. |